These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 3942595)

  • 1. Mutagenicity of chloroolefins in the Salmonella/mammalian microsome test--II. Structural requirements for the metabolic activation of non-allylic chloropropenes and methylated derivatives via epoxide formation.
    Neudecker T; Dekant W; Jörns M; Eder E; Henschler D
    Biochem Pharmacol; 1986 Jan; 35(2):195-200. PubMed ID: 3942595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutagenicity of chloroolefins in the Salmonella/mammalian microsome test. III. Metabolic activation of the allylic chloropropenes allyl chloride, 1,3-dichloropropene, 2,3-dichloro-1-propene, 1,2,3-trichloropropene, 1,1,2,3-tetrachloro-2-propene and hexachloropropene by S9 mix via two different metabolic pathways.
    Neudecker T; Henschler D
    Mutat Res; 1986; 170(1-2):1-9. PubMed ID: 3515164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity of 2- and 3-carbon halogenated compounds in the Salmonella/mammalian-microsome test.
    Stolzenberg SJ; Hine CH
    Environ Mutagen; 1980; 2(1):59-66. PubMed ID: 7035158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allyl isothiocyanate is mutagenic in Salmonella typhimurium.
    Neudecker T; Henschler D
    Mutat Res; 1985; 156(1-2):33-7. PubMed ID: 3889625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity of halogenated propanes and their methylated derivatives.
    Ratpan F; Plaumann H
    Environ Mol Mutagen; 1988; 12(2):253-9. PubMed ID: 3044786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity of chloro-olefins in the Salmonella/mammalian microsome test. I. Allyl chloride mutagenicity re-examined.
    Neudecker T; Henschler D
    Mutat Res; 1985; 157(2-3):145-8. PubMed ID: 3894959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of benzo[a]pyrene and aflatoxin B1 to mutagenic chemical species by microsomal preparations from rat liver and small intestine in relation to microsomal epoxide hydrolase.
    Walters JM; Combes RD
    Mutagenesis; 1986 Jan; 1(1):45-8. PubMed ID: 3125402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mutagenicity of mixtures of halogenated aliphatic hydrocarbons and polycyclic aromatic hydrocarbons in the Ames test with TA98 and TA100].
    Kevekordes S; Porzig J; Gebel T; Dunkelberg H
    Zentralbl Hyg Umweltmed; 1998 Feb; 200(5-6):531-41. PubMed ID: 9531725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsomal metabolism of 1-nitrobenzo[e]pyrene to a highly mutagenic K-region dihydrodiol.
    Fu PP; Heflich RH; Von Tungeln LS; Miranda HZ; Evans FE
    Carcinogenesis; 1988 Jun; 9(6):951-8. PubMed ID: 3286032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
    Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The differential mutagenicity of isoniazid in fluctuation assays and Salmonella plate tests.
    Gatehouse D; Wedd DJ
    Carcinogenesis; 1984 Mar; 5(3):391-7. PubMed ID: 6368032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
    Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
    Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-mutagenic structural modification by fluorine-substitution in highly mutagenic 4-methylquinoline derivatives.
    Kato T; Hakura A; Mizutani T; Saeki K
    Mutat Res; 2000 Feb; 465(1-2):173-82. PubMed ID: 10708984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A demonstration of the in vitro bacterial mutagenicity of procarbazine, using the microtitre fluctuation test and large concentrations of S9 fraction.
    Gatehouse DG; Paes DJ
    Carcinogenesis; 1983; 4(3):347-52. PubMed ID: 6339100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and mutagenicity of 1-nitropyrene 4,5-oxide and 1-nitropyrene 9,10-oxide, microsomal metabolites of 1-nitropyrene.
    Fifer EK; Howard PC; Heflich RH; Beland FA
    Mutagenesis; 1986 Nov; 1(6):433-8. PubMed ID: 3331683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenic properties of allylic and alpha, beta-unsaturated compounds: consideration of alkylating mechanisms.
    Eder E; Henschler D; Neudecker T
    Xenobiotica; 1982 Dec; 12(12):831-48. PubMed ID: 6763406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutagenic evaluation of trichlorfon using different assay methods with Salmonella typhimurium.
    Barrueco C; Herrera A; de la Peña E
    Mutagenesis; 1991 Jan; 6(1):71-6. PubMed ID: 2038275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinylidene chloride: changes in drug-metabolizing enzymes, mutagenicity and relation to its targets for carcinogenesis.
    Oesch F; Protić-Sabljić M; Friedberg T; Klimisch HJ; Glatt HR
    Carcinogenesis; 1983 Aug; 4(8):1031-8. PubMed ID: 6347425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the mutagenicity of azo dyes in Salmonella typhimurium: a study of structure-activity relationships.
    Shahin MM
    Mutagenesis; 1989 Mar; 4(2):115-25. PubMed ID: 2659922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.